Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells

Biochemical and Biophysical Research Communications

Volumn 412, Issue 1, 2011, Pages 175-181

  Moon, Jai Hee ^a   Kwon, Suhyun ^a   Jun, Eun Kyoung ^a   Kim, Aeree ^b   Whang, Kwang Youn ^a   Kim, Hyunggee ^a   Oh, Sejong ^c   Yoon, Byung Sun ^a   You, Seungkwon ^a  

^a Korea University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

Brain cancer stem cell like cells; Dedifferentiation; Nanog; P53 Astrocytes; Tumorigenicity

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CANCER; CANCER STEM CELL; CARCINOGENESIS; CELL DEDIFFERENTIATION; CELL FATE; CELL GROWTH; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEURAL STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ASTROCYTES; BRAIN NEOPLASMS; CELL DEDIFFERENTIATION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASTIC STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 80051790113     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.070     Document Type: Article

References (39)

1. Gal I., Kiss G.G., Szegedi L. Use of self-expanding stents in benign and malignant esophageal disease. Orv. Hetil. 2005, 146:2345-2349.
2. Beachy P.A., Karhadkar S.S., Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004, 432:324-331.
3. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 2003, 3:895-902.
4. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64:7011-7021.
5. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
6. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
7. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
8. Bachoo R.M., Maher E.A., Ligon K.L., Sharpless N.E., Chan S.S., You M.J., Tang Y., DeFrances J., Stover E., Weissleder R., Rowitch D.H., Louis D.N., DePinho R.A. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002, 1:269-277.
9. Dai C., Celestino J.C., Okada Y., Louis D.N., Fuller G.N., Holland E.C. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 2001, 15:1913-1925.
10. Dunlap S.M., Celestino J., Wang H., Jiang R., Holland E.C., Fuller G.N., Zhang W. Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc. Natl. Acad. Sci. USA 2007, 104:11736-11741.
11. Holland E.C., Celestino J., Dai C., Schaefer L., Sawaya R.E., Fuller G.N. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 2000, 25:55-57.
12. Holland E.C., Hively W.P., Gallo V., Varmus H.E. Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes. Genes Dev. 1998, 12:3644-3649.
13. Jeon H.M., Jin X., Lee J.S., Oh S.Y., Sohn Y.W., Park H.J., Joo K.M., Park W.Y., Nam D.H., DePinho R.A., Chin L., Kim H. Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes Dev. 2008, 22:2028-2033.
14. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
15. Darr H., Mayshar Y., Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 2006, 133:1193-1201.
16. Pan G., Thomson J.A. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res. 2007, 17:42-49.
17. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
18. Silva J., Chambers I., Pollard S., Smith A. Nanog promotes transfer of pluripotency after cell fusion. Nature 2006, 441:997-1001.
19. Donohoe M.E., Silva S.S., Pinter S.F., Xu N., Lee J.T. The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting. Nature 2009, 460:128-132.
20. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
21. Nagata S., Toyoda M., Yamaguchi S., Hirano K., Makino H., Nishino K., Miyagawa Y., Okita H., Kiyokawa N., Nakagawa M., Yamanaka S., Akutsu H., Umezawa A., Tada T. Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells. Genes Cells 2009, 14:1395-1404.
22. Silva J., Nichols J., Theunissen T.W., Guo G., van Oosten A.L., Barrandon O., Wray J., Yamanaka S., Chambers I., Smith A. Nanog is the gateway to the pluripotent ground state. Cell 2009, 138:722-737.
23. Clement V., Sanchez P., de Tribolet N., Radovanovic I., Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 2007, 17:165-172.
24. Po A., Ferretti E., Miele E., De Smaele E., Paganelli A., Canettieri G., Coni S., Di Marcotullio L., Biffoni M., Massimi L., Di Rocco C., Screpanti I., Gulino A. HEDGEHOG controls neural stem cells through p53-independent regulation of Nanog. EMBO J. 2010, 29:2646-2658.
25. Zbinden M., Duquet A., Lorente-Trigos A., Ngwabyt S.N., Borges I., Ruiz i Altaba A. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J. 2010, 29:2659-2674.
26. Zhang J., Wang X., Chen B., Suo G., Zhao Y., Duan Z., Dai J. Expression of Nanog gene promotes NIH3T3 cell proliferation. Biochem. Biophys. Res. Commun. 2005, 338:1098-1102.
27. Piestun D., Kochupurakkal B.S., Jacob-Hirsch J., Zeligson S., Koudritsky M., Domany E., Amariglio N., Rechavi G., Givol D. Nanog transforms NIH3T3 cells and targets cell-type restricted genes. Biochem. Biophys. Res. Commun. 2006, 343:279-285.
28. Lee J.S., Gil J.E., Kim J.H., Kim T.K., Jin X., Oh S.Y., Sohn Y.W., Jeon H.M., Park H.J., Park J.W., Shin Y.J., Chung Y.G., Lee J.B., You S., Kim H. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras. Biochem. Biophys. Res. Commun. 2008, 365:496-502.
29. Moon J.H., Yoon B.S., Kim B., Park G., Jung H.Y., Maeng I., Jun E.K., Yoo S.J., Kim A., Oh S., Whang K.Y., Kim H., Kim D.W., Kim K.D., You S. Induction of neural stem cell-like cells (NSCLCs) from mouse astrocytes by Bmi1. Biochem. Biophys. Res. Commun. 2008, 371:267-272.
30. Vescovi A.L., Galli R., Reynolds B.A. Brain tumour stem cells. Nat. Rev. Cancer 2006, 6:425-436.
31. Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., Chou S.H., Chien C.S., Ku H.H., Lo J.F. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 2008, 14:4085-4095.
32. Ezeh U.I., Turek P.J., Reijo R.A., Clark A.T. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005, 104:2255-2265.
33. Hart A.H., Hartley L., Parker K., Ibrahim M., Looijenga L.H., Pauchnik M., Chow C.W., Robb L. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 2005, 104:2092-2098.
34. Jeter C.R., Badeaux M., Choy G., Chandra D., Patrawala L., Liu C., Calhoun-Davis T., Zaehres H., Daley G.Q., Tang D.G. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009, 27:993-1005.
35. Machida K., Tsukamoto H., Mkrtchyan H., Duan L., Dynnyk A., Liu H.M., Asahina K., Govindarajan S., Ray R., Ou J.H., Seki E., Deshaies R., Miyake K., Lai M.M. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc. Natl. Acad. Sci. USA 2009, 106:1548-1553.
36. Ye F., Zhou C., Cheng Q., Shen J., Chen H. Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 2008, 8:108.
37. Yasuda S.Y., Tsuneyoshi N., Sumi T., Hasegawa K., Tada T., Nakatsuji N., Suemori H. NANOG maintains self-renewal of primate ES cells in the absence of a feeder layer. Genes Cells 2006, 11:1115-1123.
38. Theunissen T.W., van Oosten A.L., Castelo-Branco G., Hall J., Smith A., Silva J.C. Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr. Biol. 2011, 21:65-71.
39. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.